ARCA Biopharma Inc (NASDAQ:ABIO)

0.557
Delayed Data
As of Jun 15
 +0.0458 / +8.96%
Today’s Change
0.45
Today|||52-Week Range
2.71
-58.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-9.7M-11.4M-16.4M-18.5M
 
 
 
 
 
Depreciation12.0K19.0K24.0K27.0K
 
 
 
 
 
Total Other Cash Flow714.0K788.0K1.0M906.0K
 
 
 
 
 
Funds From Operations-9.0M-10.6M-15.4M-17.6M
 
 
 
 
 
Funds From/For Other Operating Expenses443.0K-104.0K-400.0K-85.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-9.4M-10.5M-15.0M-17.5M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-20.5M-5.5M
 
 
 
Decrease In Investments0.000.004.1M18.4M
 
 
 
Capital Expenditures-19.0K-11.0K-12.0K-3.0K
 
 
 
 
 
Net Cash Flow Investing-19.0K-11.0K-16.4M12.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings0.000.00--0.00--
Long Term Debt Reduction0.000.00--0.00--
Net Proceeds Stock Sale8.2M34.2M0.006.1M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing179.0K193.0K0.00256.0K
 
 
 
 
Net Cash Flow - Financing8.0M34.0M0.005.8M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-1.4M23.4M-31.4M1.3M